Ann: Updated Strategy and Investor Presentation, page-436

First 436 Last

Share
Profile

Follow
Davisite

19,420 Posts.

6515

05/12/23

19:17

Post #: 71287699
Share

Originally posted by Moonwalker101 ↑

Every minute that Dr T has spent answering questions following the release of the new strategy has been time well spent.

Like many shareholders here, I'm a biotech novice who at best has a "macro" understanding of this industry and the science involved.

Without his contribution here, this forum would have degenerated into a cacophonous quagmire of confusion, disinformation, misinformation, and brawling over what the new strategy may or may not entail.

Treating shareholders with dismissive contempt is par for the course in this game, which makes Dr T's approach all the more refreshing and reassuring for the average shareholder whose risking their hard-earned money in pursuit of that dream escape from the rat race.

I'm here for the long haul, and I'll be exercising my options as soon as possible to do my part and help fund this new strategy.

Expand

Thanks for the very kind words. Even if RAC is not the company for many people reading my posts, I hope they at least get a better understanding of how the biotech sector works. As I have said many time before, Australia has all the factors required to become a biotech powerhouse (good scientists, good regulatory environment, excellent government support) except for informed and educated investors. This last hurdle can be solved.

RAC Price at posting: 89.5¢ Sentiment: Buy Disclosure: Held
43 Upvote

3 Great analysis

Reply

Top Stories

Making money: How many microcaps should be in an investor's portfolio?

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too